Advanced search    

Search: authors:"Mark S. Shiroishi"

3 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

A pilot study of pre-operative motor dysfunction from gliomas in the region of corticospinal tract: Evaluation with diffusion tensor imaging

conflicts of interest-Bo Gao. (PDF) Author Contributions Conceptualization: Bo Gao, Mark S. Shiroishi, Zhiqian Li, Guiquan Shen. Data curation: Bo Gao, Xudong Shen, Mark S. Shiroishi, Mingfan Pang, Zhiqian ... Li, Benxia Yu, Guiquan Shen. Formal analysis: Bo Gao, Xudong Shen, Mark S. Shiroishi, Zhiqian Li, Benxia Yu, Guiquan Shen. Funding acquisition: Bo Gao, Zhiqian Li, Guiquan Shen. Investigation: Bo

Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma

Aside from bidimensional measurements from conventional contrast-enhanced MRI, there are no validated or FDA-qualified imaging biomarkers for high-grade gliomas. However, advanced functional MRI techniques, including perfusion- and diffusion-weighted MRI, have demonstrated much potential for determining prognosis, predicting therapeutic response, and assessing early treatment...

A Pilot Genome-Scale Profiling of DNA Methylation in Sporadic Pituitary Macroadenomas: Association with Tumor Invasion and Histopathological Subtype

experiments. This work was not sponsored by Zymo Research, nor does Zymo Research have an interest in the results of this research. Mark S. Shiroishi is a consultant for Bayer Pharma AG. This work is not